Eli Lilly just paused its COVID-19 antibody drug trial over safety concerns – Business Insider – Business Insider

Eli Lilly paused trials of its monoclonal antibody treatment for Covid-19 after an independent board of experts raised health concerns, the company said Tuesday.
“We are aware that, out of an abunda… [+1288 chars]